Study reveals mechanisms behind common mutation and prostate cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 2-Nov-2025 21:11 ET (3-Nov-2025 02:11 GMT/UTC)
A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct classes of mutations in the FOXA1 gene—commonly altered in prostate cancer—drive tumor initiation formation and therapeutic resistance.